Stay updated on AVR-RD-01 in Treatment-Naive Classic Fabry Disease Clinical Trial

Sign up to get notified when there's something new on the AVR-RD-01 in Treatment-Naive Classic Fabry Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVR-RD-01 in Treatment-Naive Classic Fabry Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a modification in the number of male subjects (n=5) who did not complete the study due to the termination of the Fabry disease development program by the study sponsor.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:08.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying that researchers are looking for males aged 16 or older with a confirmed diagnosis of classic Fabry disease, among other health-related conditions. Previously, no information was provided under the Participation Criteria Collaborators section.
    Difference
    25%
    Check dated 2024-05-22T21:00:22.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:35:23.000Z thumbnail image

Stay in the know with updates to AVR-RD-01 in Treatment-Naive Classic Fabry Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVR-RD-01 in Treatment-Naive Classic Fabry Disease Clinical Trial page.